MedPath

Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma

Phase 2
Completed
Conditions
Sarcoma
Kidney Cancer
Ovarian Cancer
Metastatic Cancer
Melanoma (Skin)
Registration Number
NCT00003308
Lead Sponsor
Eastern Cooperative Oncology Group
Brief Summary

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells.

PURPOSE: Phase II trial to study the effectiveness of radiation therapy in treating patients with newly diagnosed brain metastases from kidney cancer, melanoma, or sarcoma.

Detailed Description

OBJECTIVES:

* Evaluate whether the delivery of stereotactic radiosurgery without conventional whole brain radiotherapy is feasible in patients with 1-3 newly diagnosed brain metastases from renal cell carcinoma, melanoma, or sarcoma.

* Determine the 3-, 6-, and 12-month radiographic and neurologic intracranial patterns of progression (i.e., original lesions vs new lesions) in patients treated with this regimen.

OUTLINE: This is a multicenter study. Patients are stratified according to maximum tumor diameter (2 cm vs greater than 2 cm to 3 cm vs greater than 3 cm to 4 cm).

Patients undergo stereotactic radiosurgery at an assigned dose according to tumor diameter. Patients undergo MRI or CT scan at 3, 6, and 12 months after treatment or until disease progression.

All other therapies are allowed after stereotactic radiosurgery except external beam whole brain radiotherapy or resection of brain metastases, unless there is documented progression or unrelenting mass effect that necessitates craniotomy.

Patients are followed every 3 months for 2 years.

PROJECTED ACCRUAL: A total of 36 patients will be accrued for this study within 7.2 months.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (14)

Iowa Methodist Medical Center

πŸ‡ΊπŸ‡Έ

Des Moines, Iowa, United States

Milton S. Hershey Medical Center

πŸ‡ΊπŸ‡Έ

Hershey, Pennsylvania, United States

Veterans Affairs Medical Center - Madison

πŸ‡ΊπŸ‡Έ

Madison, Wisconsin, United States

Mercy Medical Center

πŸ‡ΊπŸ‡Έ

Des Moines, Iowa, United States

Westmead Hospital

πŸ‡¦πŸ‡Ί

Westmead, New South Wales, Australia

Alegent Health-Midlands Community Hospital

πŸ‡ΊπŸ‡Έ

Papillion, Nebraska, United States

Iowa Lutheran Hospital

πŸ‡ΊπŸ‡Έ

Des Moines, Iowa, United States

CCOP - Kalamazoo

πŸ‡ΊπŸ‡Έ

Kalamazoo, Michigan, United States

Ireland Cancer Center

πŸ‡ΊπŸ‡Έ

Cleveland, Ohio, United States

CCOP - St. Vincent Hospital Cancer Center, Green Bay

πŸ‡ΊπŸ‡Έ

Green Bay, Wisconsin, United States

University of Wisconsin Comprehensive Cancer Center

πŸ‡ΊπŸ‡Έ

Madison, Wisconsin, United States

Instituto de Enfermedades Neoplasicas

πŸ‡΅πŸ‡ͺ

Lima, Peru

San Juan City Hospital

πŸ‡΅πŸ‡·

San Juan, Puerto Rico

MBCCOP - University of New Mexico HSC

πŸ‡ΊπŸ‡Έ

Albuquerque, New Mexico, United States

Β© Copyright 2025. All Rights Reserved by MedPath